RR

Reshma Rani

Jubilant Biosys Ltd, Amity University, National cancer Institute-CRO Aviano Italy

ORCID iD 0000-0003-4937-0689

About

The primary research interest of Dr. ReshmaRani is Target and Fragment Based Drug Design and Drug Discovery for several metabolic cancers including Pancreatic, Breast, stomach and Head & Neck cancer via targeting cellular energetics of cancer cell vs healthy cells. She established her independent lab focuses on design and synthesis of small drug like molecules that inhibit the enzyme or proteins overexpressed in cancers, inflammation and malaria. She also design and synthesized small molecules which are potential inhibitors of human Lactate dehydrogenase enzymes (hLDH5) involved in tumor glycolysis. She has worked on synthesis of drug like molecules by microwave assisted synthesis and green chemistry. Her future research interest focuses on Target and Fragment based drug discovery, green chemistry and target based drug delivery. In addition to research, she is teaching Basic Organic Chemistry, Reaction mechanism, Chemical Biology and Bioanalytical techniques (IR, NMR, GC-Mass, FAB-MS).

Employment

  • Jubilant Biosys Ltd Team Leader
    2022 - Present
  • Amity University Assistant Professor
    2016 - 2022
  • National cancer Institute-CRO Aviano Italy
    2014 - 2015
  • Marie Curie Postdoctoral Fellow
    2012 - 2014
  • Osaka University Postdoctoral researcher
    2011 - 2012

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications

Publications are unavailable.